New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

PTHvsXPHETF Comparison

ETF 1
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-1.08%
VS
ETF 2
XPH

State Street SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
-1.08%

Invesco DWA Healthcare Momentum ETF (PTH) and State Street SPDR S&P Pharmaceuticals ETF (XPH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is more expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.35% for XPH. PTH is up 4.86% year-to-date (YTD) with -$6M in YTD flows. XPH performs worse with 2.61% YTD performance, and +$116M in YTD flows. Run a side-by-side ETF comparison of PTH and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PTH vs XPH performance and flow charts

Performance

051015%Mar 24Mar 31Apr 8Apr 15Apr 22

Cumulative Flows

0 M5 M10 M15 M20 M25 MMar 24Mar 31Apr 8Apr 15Apr 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
PTH
XPH
+12.30%+9.68%
+6.29%+2.44%
+4.86%+2.61%
+38.78%+44.99%
+31.58%+40.83%
+0.54%+22.16%
Flows
PTH
XPH
-$2M+$25M
-$5M+$82M
-$6M+$116M
-$10M+$141M
-$81M+$48M
-$357M+$64M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PTH
XPH
+26.84%+24.78%
+22.82%+21.12%
+24.56%+19.49%
+25.26%+20.45%
Max drawdown
PTH
XPH
-7.51%-11.78%
-11.91%-11.78%
-29.24%-23.45%
-50.10%-31.59%
Max drawdown duration
PTH
XPH
40d50d
140d50d
271d322d
1695d1566d
Trading data

Create an account to view trading data

Join for free
PTH
XPH
Last sale
4/24/2026 at 1:30 PM
$52.13
$57.40
Previous close
04/23/2026
$52.31
$57.20
Consolidated volume
04/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PTH
XPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/24/2026 at 1:30 PM
Live
Closed
PTH
XPH
Last price
$52.13
$57.40
1D performance
-0.34%
+0.35%
AuM$125.11 M$353.54 M
E/R0.72%0.35%
Characteristics
PTH
XPH
Management strategyPassivePassive
ProviderInvescoState Street Investment Management
BenchmarkDorsey Wright Healthcare Technical Leaders IndexS&P Pharmaceuticals Select Industry Index
N° of holdings4648
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 12, 2006June 19, 2006
ESGNoNo
Advertisement
Exposure

Countries

PTH
USA
94.53%
Other
5.47%
XPH
USA
87.77%
Other
12.23%

Sectors

PTH
Health Care
85.2%
Other
14.8%
XPH
Health Care
82.36%
Other
17.64%
Advertisement

Diversification

PTH

Total weight of top 15 holdings out of 15

52.67%
XPH

Total weight of top 15 holdings out of 15

30.65%

Top 15 holdings

Data as of March 31, 2026
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
XPH
US29337E1029
2.45%
CORCEPT THERAPEUTICS
2.29%
TERNS PHARMACEUTICALS
2.16%
PERRIGO CO PLC
2.10%
AXSOME THERA CMN STK
2.03%
INNOVIVA INC
1.99%
MERCK & CO INC
1.98%
PFIZER
1.97%
ROYALTY PHARMA
1.97%
ELANCO ANIMAL HEALTH INC
1.96%
JAZZ PHARMACEUTICALS
1.96%
ESPERION THERAPEUTICS
1.95%
EDGEWISE THERAPEUTICS
1.95%
US55287L1017
1.95%
BRISTOL-MYERS SQUIBB
1.94%
Frequently asked questions about PTH and XPH

How have the PTH and XPH ETFs performed in 2026?

As of April 24, 2026, PTH is up 4.86% year-to-date (YTD), while XPH has returned 2.61%. That puts PTH better performer ahead so far this year.

Which ETF is attracting more investor money: PTH or XPH?

Year-to-date, the PTH ETF saw -$6M in flows, compared to +$116M for XPH.

Which ETF is more volatile: PTH or XPH?

Over the past year, PTH had a volatility of 22.82%, while XPH experienced 21.12%.

Which ETF is bigger: PTH or XPH?

As of April 24, 2026, PTH holds $125.11 M in assets under management (AUM), while XPH manages $353.54 M.

What sectors do the PTH and XPH ETFs invest in?

PTH leans toward sectors like Health Care. Meanwhile, XPH focuses on Health Care.

What are the top holdings of the PTH ETF and XPH ETF?

PTH top holdings include TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070. XPH holds in its top three: US29337E1029, CORCEPT THERAPEUTICS and TERNS PHARMACEUTICALS.

Which ETF is more diversified: PTH or XPH?

PTH holds 57 securities with 52.67% of its assets in the top 15. XPH has 57 securities and a top 15 weight of 30.65%.

Advertisement
Advertisement
Advertisement
Webcast on Demand

Calamos Investments Powers the Next Phase of the Autocallable Revolution

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.

Accepted for 1 CE Credit

Calamos Webcast